Drug intelligence / Profile preview

polyethylene glycol 3350 + bisacodyl

Development stage
Phase 4
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol 3350 + bisacodyl is a combination of two laxatives—polyethylene glycol 3350 (an osmotic laxative) and bisacodyl (a stimulant laxative)—formulated for oral use to clean out the gastrointestinal tract prior to colonoscopy[2][3][7]. Polyethylene glycol 3350 retains water in the colon through osmotic action, causing catharsis, while bisacodyl is hydrolyzed in the colon to its active metabolite and stimulates peristaltic activity in the large intestine[3]. This combination is indicated for bowel cleansing prior to colonoscopy, with effectiveness dependent on correct dosing and administration[2][3]. The regimen is associated with potential risks such as electrolyte abnormalities, dehydration, and ischemic colitis, particularly if overdosed[3][7]. Major US brands for the combination include GaviLyte-H and Bisacodyl and HalfLytely and Bisacodyl[2][3][7]. The combination is generally administered as a single kit: an oral bisacodyl tablet followed by reconstituted polyethylene glycol 3350 solution (with electrolytes)[3]. Use is contraindicated in patients with gastrointestinal obstruction, bowel perforation, toxic colitis, toxic megacolon, gastric retention, ileus, and certain hypersensitivities[2][3].

Brand names
GaviLyte-H and BisacodylHalfLytely and BisacodylPEG-Prep and Bisacodyl
Other names
bisacodyl and polyethylene glycol 3350bisacodyl + polyethylene glycol 3350bisacodyl and PEG-3350 with electrolytes

Beyond the preview

Go deeper on polyethylene glycol 3350 + bisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 3350 + bisacodyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call